If you are:
Only When Necessary: ONLY AVAILABLE IN COMBINATION PRODUCTS THAT ARE ASSIGNED FDA CATEGORY C.
FDB Only When Necessary: INSUFFICIENT DATA AVAILABLE; SIMILAR DRUG, MECLIZINE COMPATIBLE PER BRIGGS
Only When Necessary: EVIDENCE FOR MALFORMATIONS; CAN REDUCE UTERINE BLOOD FLOW CAUSING FETAL HYPOXIA
Precaution: INSUFFICIENT DATA AVAILABLE
Precaution: INSUFFICIENT DATA AVAILABLE.
Precaution: ORAL BIOAVAILABILITY LOW; INFANT EXPOSURE MAY BE MINIMAL
An adult over 60:
management or monitoring precaution: Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
management or monitoring precaution: Increased risk of hypotension, hyperexcitability, and anticholinergic side effects.
Giving Vanacof-PE Tablet, Chewable to a child under 12:
Contraindication: Risk of CNS effects. Not recommended age < 6 years unless clinician consult.
Contraindication: Possible CNS excitation and seizure risk in newborns.
Contraindication: Possible excitation, increased sensitivity to CNS effects. Do not use without clinician consult.
Contraindication: Risk of CNS excitation. Do not use age <6 years without clinician consult.